| Literature DB >> 30076500 |
Grant W Ralston1, Lon Kilgore2, Frank B Wyatt3, Duncan Buchan4, Julien S Baker4.
Abstract
BACKGROUND: The current recommendations for resistance training (RT) frequency range from 2 to 5 days per week (days week- 1) depending on the subjects' training status. However, the relationship between RT frequency and muscular strength remains controversial with reported variances existing across different population groups. We conducted a meta-analysis that (1) quantified the effects of low (LF; 1 day week- 1), medium (MF; 2 days week- 1), or high (HF; ≥ 3 days week- 1) RT frequency on muscular strength per exercise; (2) examined the effects of different RT frequency on one repetition maximum (1RM) strength gain profiles (multi-joint exercises and single joint exercises); (3) examined the effects of different RT frequency on 1RM strength gain when RT volume is equated; and (4) examined the effects of different RT frequency on 1RM strength gains on upper and lower body.Entities:
Keywords: Resistance training frequency for strength development; Strength training frequency
Year: 2018 PMID: 30076500 PMCID: PMC6081873 DOI: 10.1186/s40798-018-0149-9
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Methodological quality of studies based on the PEDro score
| Author (ref) | PEDro scale item | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1a | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
| Carroll et al. [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| McLester et al. [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Brigatto et al. [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Gentil et al. [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Murlasits et al. [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Silva et al. [ | Yes | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
| DiFranciso-Donoghue et al. [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Lera Orsatti et al. [ | Yes | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 4 |
| Candow and Burke [ | Yes | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6 |
| Schoenfeld et al. [ | Yes | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
| Thomas and Burns [ | Yes | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
| Arazi and Asadi [ | Yes | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5 |
PEDro Physiotherapy Evidence Database. The PEDro scale is based on the Delphi list [25]. Column 1a not used in the calculation of the scores. Only criterion 2–11 are scored giving a total out of 10. Column numbers correspond to the following criteria on the PEDro scale: 1 = eligibility criteria (1a = eligibility criteria specified [yes/no]); 2 = random allocation; 3 = concealed allocation; 4 = groups similar at baseline; 5 = blinded subjects; 6 = blinded therapists; 7 = blinded assessors; 8 = follow-up measures obtained for > 85% of subjects; 9 = intention to treat analysis; 10 = between-groups statistical comparison; 11 = point measures and measures of variability
Excluded studies from meta-analysis due to confounding factors
| Study |
| Age, years (mean ± SD) | Duration | Testing modality | Sets (reps) | Days trained per week | Frequency per week | Pre- vs. post-intervention kg, | Pre- vs. post-intervention | ES | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gomes et al. [ | 12 | 25.5 (± 1.25) | 8 weeks | Sq | 5–10 (8–12) | 1 | LF | 132.9 ± 28.0 vs. 140.9 ± 25.5 | 8 (6.02) | 0.47 | 0.30 |
| Gomes et al. [ | 12 | 25.5 (± 1.25) | 8 weeks | BP | 5–10 (8–12) | 1 | LF | 103.5 ± 15.4 vs. 109.1 ± 18.5 | 5.6 (5.41) | 0.43 | 0.33 |
| Serra et al. [ | 26 | 35.3 (± 1.75) | 3 months | WG PullD | 3 (10–20) | 2 | MF | 42.6 ± 20.7 vs. 48.5 ± 20.7 | 5.9 (13.8) | ≤ 0.001 a | 0.29 |
| Serra et al. [ | 26 | 35.3 (± 1.75) | 3 months | CP | 3 (10–20) | 2 | MF | 41.2 ± 25.6 vs. 49.9 ± 30.2 | 8.7 (21.1) | ≤ 0.001a | 0.31 |
| Serra et al. [ | 26 | 35.3 (± 1.75) | 3 months | LP | 3 (10–20) | 2 | MF | 108.9 ± 49.1 vs. 128.9 ± 54.5 | 20 (18.4) | ≤ 0.001a | 0.39 |
| Yue et al. [ | 9 | 28 (± 7.9) | 6 weeks | Sq | 4 (8–12) | 2 | MF | 103 ± 27 vs. 115 ± 34 | 12 (11.7) | ≤ 0.001a | 0.39 |
| Yue et al. [ | 9 | 28 (± 7.9) | 6 weeks | BP | 4 (8–12) | 2 | MF | 77 ± 27 vs. 88 ± 30 | 11 (14.3) | ≤ 0.001a | 0.39 |
| Carpenter et al. [ | 10 | 31(± 31) | 20 weeks | LumExt | 1 (8–12) | 0.5 | LF | 73.6 ± 24.7 vs. 98.2 ± 32.8 | 24.6 (33.4) | ≤ 0.05b | 0.85 |
| Pollock et al. [ | 14 | 26 (± 9) | 12 weeks | CervExt | 1 (8–12) | 1 | LF | 28.3 ± 6.7 vs. 38.2 ± 7.8 | 9.9 (35.0) | 0.001a | 1.36 |
| Taaffe et al. [ | 11 | 68.5 (± 3.6) | 24 weeks | LPull | 3 (8) | 1 | LF | 36.0 ± 14.2 vs. 45.3 ± 4.31 | 9.3 (25.83) | ≤ 0.001a | 0.89 |
| Taaffe et al. [ | 11 | 68.5 (± 3.6) | 24 weeks | BC | 3 (8) | 1 | LF | 16.5 ± 7.1 vs. 21.9 ± 2.99 | 5.4 (32.73) | ≤ 0.001a | 0.99 |
| Taaffe et al. [ | 11 | 68.5 (± 3.6) | 24 weeks | BExt | 3 (8) | 1 | LF | 62.3 ± 24.5 vs. 83.1 ± 9.17 | 20.8 (33.39) | ≤ 0.001a | 1.12 |
| Taaffe et al. [ | 11 | 68.5 (± 3.6) | 24 weeks | LP | 3 (8) | 1 | LF | 109.5 ± 29.8 vs. 135.2 ± 12.27 | 25.7 (23.47) | ≤ 0.001a | 1.13 |
| Taaffe et al. [ | 11 | 68.5 (± 3.6) | 24 weeks | KExt | 3 (8) | 1 | LF | 39.3 ± 15.4 vs. 67.1 ± 10.95 | 27.8 (70.74) | ≤ 0.001a | 2.08 |
| Taaffe et al. [ | 10 | 68.5 (± 3.6) | 24 weeks | KFlex | 3 (8) | 1 | LF | 16.3 ± 7.5 vs. 28.4 ± 4.43 | 12.1 (74.23) | ≤ 0.001a | 1.96 |
| Farinatti et al. [ | 10 | 72 (± 5.0) | 16 weeks | DumBP | 1 (8–12) | 1 | LF | 8.2 ± 1.8 vs. 13.0 ± 2.0 | 4.8 (58.54) | ≤ 0.01a | 2.52 |
| Farinatti et al. [ | 10 | 72 (± 5.0) | 16 weeks | DCur | 1 (8–12) | 1 | LF | 7.8 ± 1.5 vs. 12.2 ± 2.3 | 4.4 (56.41) | ≤ 0.01a | 2.27 |
| Farinatti et al. [ | 10 | 72 (± 5.0) | 16 weeks | KExt | 1 (8–12) | 1 | LF | 18.0 ± 3.7 vs. 25.6 ± 3.2 | 7.6 (42.22) | ≤ 0.01a | 2.20 |
| Farinatti et al. [ | 10 | 72 (± 5.0) | 16 weeks | StCR | 1 (8–12) | 1 | LF | 12.0 ± 2.0 vs. 16.8 ± 1.9 | 4.8 (40.0) | ≤ 0.01a | 2.46 |
| Burt et al. [ | 10 | Students | 8 weeks. | LP | 1 (6–10) | 1 | LF | 263.31 ± 37.23 vs. 362.65 ± 51.06 | 99.34 (99.34) | ≤ 0.0001a | 2.22 |
| Serra et al. [ | 18 | 41.4 (± 9.9) | 4 months | BP | 3 (10–12) | 2 | MF | 41.7 ± 16.4 vs. 57.4 ± 15.4 | 36.3 (37.6) | 0.01a | 0.99 |
| Serra et al. [ | 18 | 41.4 (± 9.9) | 4 months | LP | 3 (10–12) | 2 | MF | 83.3 ± 21.4 vs. 113.3 ± 26.6 | 30.4 (36.01) | 0.001a | 1.24 |
| Serra et al. [ | 18 | 41.4 (± 9.9) | 4 months | LPull | 3 (10–12) | 2 | MF | 50.1 ± 12.0 vs. 67.4 ± 12.0 | 29.4 (34.5) | 0.0001a | 1.44 |
| Benton et al. [ | 11 | 47.6 (± 1.2) | 8 weeks | CP | 3–6 (8–12) | 3 | HF | 37.4 ± 2.5 vs. 50.0 ± 3.5 | 12.6 (34.0) | ≤ 0.001a | 1.25 |
| Benton et al. [ | 11 | 47.6 (± 1.2) | 8 weeks | LP | 3–6 (8–12) | 3 | HF | 105.1 ± 9.8 vs. 135.7 ± 16.7 | 30.6 (29.1) | ≤ 0.001a | 0.67 |
| Ribeiro et al. [ | 5 | 26.7 (± 2.7) | 4 weeks | BP | 4 (6–20) | 4 | HF | 104.4 ± 19.3 vs. 113.2 ± 23.0 | 8.8 (8.4) | 0.53 | 0.41 |
| Hoffman et al. [ | 12 | 19.7 ± (1.4) | 10 weeks. | BP | 1–5 (2–10) | 3 | HF | 107.2 ± 11.6 vs. 109.1 ± 28.7 | 1.9 (1.8) | 0.83 | 0.09 |
| Hoffman et al. [ | 12 | 19.7 ± (1.4) | 10 weeks. | Sq | 1–5 (2–10) | 3 | HF | 140.1 ± 18.6 vs. 147.4 ± 38.9 | 7.3 (5.2) | 0.56 | 0.24 |
| Padilha et al. [ | 13 | 68.9 (± 5.0) | 12 weeks | CP | 1 (10–15) | 2 | MF | 35.7 ± 6.6 vs. 42.2 ± 8.0 | 6.5 (18.2) | ≤ 0.05b | 0.89 |
| Padilha et al. [ | 13 | 68.9 (± 5.0) | 12 weeks | LE | 1 (10–15) | 2 | MF | 41.3 ± 9.3 vs. 48.9 ± 9.1 | 7.6 (18.4) | ≤ 0.05b | 0.83 |
| Padilha et al. [ | 13 | 66.7 (± 13.9) | 12 weeks | BC | 1 (10–15) | 2 | MF | 17.0 ± 3.3 vs. 23.4 ± 3.8 | 6.4 (37.6) | ≤ 0.05b | 1.80 |
| Hunter [ | 14 | 22.2 (± 2.2) c | 7 weeks | BP | 2–3 (7–10) | 3 | HF | 69.1 ± 22.08 vs. 77.3 ± 20.58 | 8.2 (11.9) | 0.32 | 0.38 |
| Hunter [ | 11 | 23.1 (± 0.9) d | 7 weeks | BP | 2–3 (7–10) | 3 | HF | 26.1 ± 5.97 vs. 31.3 ± 6.30 | 5.2 (19.9) | 0.32 | 0.85 |
Abbreviations: N number of subjects, SD standard deviation, reps repetitions; per week number of days trained per week, ES effect size, Sq squat, LF low frequency (1 day per week), MF medium frequency (2 days per week), HF high frequency (≥ 3 day per week), BP bench press, WGPullD wide grip pulldown, CP chest press, LP leg press, LumExt lumbar extension, CervExt cervical extension, LPull lateral pulldown, BC bicep curl, BExt back extension, LP leg press, KExt knee extension, KFlex knee flexion, DumBP dumbbell bench press, DCurl dumbbell curl, StCR standing calf raise
aSignificantly greater than prior to training (p ≤ 0.01)
bSignificantly greater than prior to training (p ≤ 0.05)
cMale-only subjects
dFemale-only subjects
Fig. 1The flow of journal articles through the systematic review process
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
|---|---|
| Strength assessment of one or more muscle groups used (isolation exercises, e.g. leg extension with stress gauge). | Small subject sample groups (e.g. |
| Minimum duration of training intervention is 3 weeks; longitudinal studies would be preferred (greater than 12 weeks). | Legal or illegal ergogenic aids or supplementation has been used during interventions. |
| Preferred if control group included within research design with subjects randomly assigned to groups. | Variation within the training order throughout the weeks. |
| RT program supervised with the RT intervention of similar order and if applicable inter-set recovery periods standardised for multiple sets. | No quasi RCT or narrative studies/reviews to be included. |
| Conducted warm-up is standardised between groups. | Subjects below 18 years of age. |
| Subjects trained to volitional fatigue with appropriate criteria regarding training intensity. | Did not report results adequately (pre- to post-mean and standard deviation). |
| Comparison of one vs. two, and ≥ three training session per week. | Examined the effects of concurrent training (i.e. combined RT and endurance training). |
| Investigated the effects of nutritional supplements in combination with RT. | |
| Concurrent aerobic and strength training interventions. |
Fig. 2Galbraith plot used to examine study heterogeneity (pre- vs. post-strength change). Each dot represents one pre- vs. post-study data. Seven pre- vs. post-study data identified as outliers (solid filled black circles)
Fig. 3Galbraith plot with the removal of seven pre- vs. post-intervention study outliers [20, 21, 23, 40–43]. Each open circle represents one pre- vs.-post-intervention study datum
Characteristics of included meta-analysis studies investigating adaptations and recovery to strength training at various frequencies
| Study | Design | Weekly volume equated? |
| Status | Sex | Age, years (mean ± SD) | Frequency | Duration | Sets | Reps | Training load | Strength outcomes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carroll et al. [ | RCT | Yes | 17 | U | M | 18.6 (± 0.9) | 2 vs. 3 days week | 6 weeks | 3 | 4–10 | 4-20RM | 1RM Squat |
| McLester et al. [ | RAN | Yes | 25 | T | M | 25.5 (± 5.1) | 1 vs. 3 days week | 12 weeks | 1–3 | 3–10 | Periodized 75–90% 1RM | 1RM Bench press, latissimus pulldown, tricep press, bicep curl, lateral raise |
| Brigatto et al. [ | RAN | Yes | 18 | T | M | 27.1(± 5.5) | 1 vs. 2 days week | 8 weeks | 4–8 | 8–12 | 8–12 RM | 1RM Bench press, 1RM squat |
| Gentil et al. [ | RAN | Yes | 30 | U | M | (23.0 ± 3.0) | 1 vs. 2 days week | 10 weeks | 3 | 8–12 | 8- 12RM | Maximum elbow extensor torque |
| Murlasits et al. [ | RAN | No | 24 | U | M | 64 (± 3) | 1 vs. 3 days week | 8 weeks | 3 | 6–8 | 75% 1RM | 3 - 5RM Leg press, chest press exercises |
| Silva et al. [ | RAN | No | 30 | U | F | 68.15 (± 4.8) | 2 vs. 3 days week | 24 weeks | 1–2 | 10–15 | 10–15 RM | Total of chest press, leg extension, biceps curl |
| DiFranciso-Donoghue et al. [ | RAN | No | 18 | U | M | 75.2 (± 1.2) | 1, 2 days week | 9 weeks | 1 | 10–15 | 75% 1RM | 1RM Leg press, chest fly, leg curl, seated dip, leg extension, arm curl. |
| Lera Orsatti et al. [ | RAN | No | 30 | U | F | 58.3 (± 8.1) | 1, 2, or 3 days week | 16 weeks | 1–3 | 8–12 | 60–80% 1RM | 1RM Bench press, leg press, leg extension, bicep curl, tricep pulley, |
| Candow and Burke [ | RAN | Yes | 29 | U | M | 43 (± 10.6) | 2 vs. 3 days week | 6 weeks | 2–3 | 10 | 60–90% 1RM | 1RM Bench press, 1RM squat |
| Schoenfeld et al. [ | RAN | Yes | 20 | T | M | (23.5 ± 2.9) | 1 vs. 3 days week | 8 weeks | 2–3 | 8–12 | 8–12 RM | 1RM Bench press |
| Thomas and Burns [ | RAN | Yes | 19 | T | M | 34.7 (± 6.9) | 1 vs. 3 days week | 8 weeks | 3 | 8–12 | 75–85% 1RM | 1RM Chest press, 1RM hack squat |
| Arazi and Asadi [ | RCT | Yes | 39 | U | M | 20.33 (± 2.1) | 1 vs. 2 days week | 8 weeks | 1 | 6–12 | 60–80% 1RM | 1RM Bench press, 1RM leg press |
Abbreviations: N number, SD standard deviation, Reps repetitions, RCT randomised controlled trial, U untrained, M male, F female, days week days per week, RM repetition maximum, 1RM 1 repetition maximum, RAN randomly assigned trial, T trained, % 1RM percentage of subjects one repetition maximum
Fig. 4Lower vs. higher weekly training frequency. Pre- vs. post-mean ES strength difference on multi-joint and isolation exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size and rhombs’ meta-analytically pooled estimates
Pre- vs. post-strength analysis of multi-joint exercise and isolation exercise
| Study |
| Age (mean ± SD) years | Duration | Testing modality | Sets | Days trained per week | Frequency per week | Pre- vs post-intervention kg, | Pre- vs post-intervention | ES | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Carroll et al. [ | 6 | 18.6 (± 0.9) | 9 weeks | Sq | 1–3 (4–10) | 2 | MF | 115 ± 29 vs 141 ± 29 | 26 (22.6) | ≤ 0.05a b | 0.900.83 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | BP | 1–3 (3–10) | 1 | LF | 75.6 ± 27.8 vs 83.6 ± 30.6 | 8.01 (10.6) | 0.57 | 0.27 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | LPull | 1–3 (3–10) | 1 | LF | 65.1 ± 20.9 vs 77.8 ± 22.9 | 12.69 (19.5) | 0.24 | 0.58 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | TriPush | 1–3 (3–10) | 1 | LF | 30.4 ± 10.3 vs 38.2 ± 13.5 | 7.77 (25.5) | 0.19 | 0.65 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | BC | 1–3 (3–10) | 1 | LF | 35.01 ± 14.8 vs 43.1 ± 16.8 | 8.07 (23.1) | 0.30 | 0.51 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | LatR | 1–3 (3–10) | 1 | LF | 22.7 ± 7.5 vs 32.3 ± 10.5 | 9.63 (42.2) | 0.04 | 1.05 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | LP | 1–3 (3–10) | 1 | LF | 200.3 ± 83.1 vs 244.9 ± 80.9 | 44.6 (22.3) | 0.23 | 0.54 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | LE | 1–3 (3–10) | 1 | LF | 62.8 ± 13.6 vs 84.2 ± 19.9 | 21.41 (34.1) | 0.02a | 1.26 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | LC | 1–3 (3–10) | 1 | LF | 57.5 ± 15.5 vs 72.0 ± 10.3 | 14.5 (25.2) | 0.03a | 1.10 |
| McLester et al. [ | 9 | 25.5 (± 5.1) | 12 weeks | CR | 1–3 (3–10) | 1 | LF | 178.0 ± 24.2 vs 215.1 ± 15.3 | 37.1 (20.8) | 0.001a | 1.83 |
| Brigatto et al. [ | 10 10 | 28.6 (± 5.6) | 8 weeks | Sq | 8 (8–12) | 1 | LF | 128.5 ± 18.6 vs 148.6 ± 21.7 | 20.1 (13.5) | ≤ 0.05a | 0.99 |
| Brigatto et al. [ | 10 | 28.6 (± 5.6) | 8 weeks | BP | 8 (8–12) | 1 | LF | 95.7 ± 14.5 vs 103.5 ± 12.9 | 7.8 (8.2) | ≤ 0.05a | 0.57 |
| Gentil et al. [ | 15 | 23.0 (± 3.0) | 10 weeks | EFlex | 3 (8–12) | 1 | LF | 50.77 ± 9.26 vs 54.15 ± 10.79 | 3.38 (6.66) | ≤ 0.05a | 0.34 |
| Murlasits et al. [ | 13 | 64 (± 3) | 8 weeks | CP | 3 (8) | 2 | MF | 43.1 ± 20.2 vs 51.8 ± 24.7 | 8.7 (20.84) | 0.01c | 0.39 |
| Murlasits et al. [ | 13 | 64 (± 3) | 8 weeks | LP | 3 (8) | 2 | MF | 158.9 ± 49.6 vs 193 ± 57.7 | 34.1 (22.34) | 0.01c | 0.63 |
| Silva et al. [ | 17 | 68.2 (± 4.8) | 24 weeks | CP, LE, BC | 1–2 (10–15) | 2 | MF | 100.6 ± 13.4 vs 117.4 ± 17.6 | 16.8 (16.8) | ≤ 0.05a | 1.07 |
| DiFranciso-Donoghue et al. [ | 9 | 75.2 (± 1.2) | 9 weeks | LP | 1 (10–15) | 1 | LF | 35.6 ± 13.5 vs 46.2 ± 15.3 | 10.6 (29.8) | ≤ 0.01c | 0.73 |
| DiFranciso-Donoghue et al. [ | 9 | 75.2 (± 1.2) | 9 weeks | LE | 1 (10–15) | 1 | LF | 34.3 ± 12.0 vs 42.9 ± 10.5 | 8.6 (25.1) | ≤ 0.01c | 0.76 |
| DiFranciso-Donoghue et al. [ | 9 | 75.2 (± 1.2) | 9 weeks | LC | 1 (10–15) | 1 | LF | 21.0 ± 8.1 vs 27.8 ± 7.5 | 6.8 (32.4) | ≤ 0.01c | 0.87 |
| DiFranciso-Donoghue et al. [ | 9 | 75.2 (± 1.2) | 9 weeks | CF | 1 (10–15) | 1 | LF | 12.8 ± 8.1 vs 18.4 ± 9.3 | 5.6 (43.8) | ≤ 0.01c | 0.64 |
| DiFranciso-Donoghue et al. [ | 9 | 75.2 (± 1.2) | 9 weeks | ArmC | 1 (10–15) | 1 | LF | 12.1 ± 6.9 vs 15.9 ± 6.6 | 3.8 (31.4) | ≤ 0.01c | 0.56 |
| DiFranciso-Donoghue et al. [ | 9 | 75.2 (± 1.2) | 9 weeks | SDip | 1 (10–15) | 1 | LF | 36.4 ± 11.4 vs 44.7 ± 9.6 | 8.3 (22.8) | ≤ 0.01c | 0.79 |
| Lera Orsatti et al. [ | 9 | 58.3 (± 8.1) | 16 weeks | BP | 3 (8–15) | 1 | LF | 30.8 ± 6.5 vs 36.5 ± 4.3 | 5.7 (18.5) | ≤ 0.01c | 1.03 |
| Lera Orsatti et al. [ | 9 | 58.3 (± 8.1) | 16 weeks | LP | 3 (8–15) | 1 | LF | 30.5 ± 5.6 vs 36.4 ± 2.2 | 5.9 (19.3) | ≤ 0.01c | 1.39 |
| Lera Orsatti et al. [ | 9 | 58.3 (± 8.1) | 16 weeks | LE | 3 (8–15) | 1 | LF | 27.7 ± 2.1 vs 30.7 ± 5.0 | 3.0 (10.8) | ≤ 0.01c | 0.78 |
| Lera Orsatti et al. [ | 9 | 58.3 (± 8.1) | 16 weeks | BC | 3 (8–15) | 1 | LF | 19.0 ± 4.0 vs 21.1 ± 2.8 | 2.1 (11.1) | ≤ 0.01c | 0.61 |
| Lera Orsatti et al. [ | 9 | 58.3 (± 8.1) | 16 weeks | TriPull | 3 (8–15) | 1 | LF | 14.3 ± 2.7 vs 16.5 ± 2.6 | 2.2 (15.4) | ≤ 0.01c | 0.83 |
| Candow and Burke [ | 15 | 42.5 (± 15.5) | 6 weeks | Sq | 2–3 (10) | 2 | MF | 39 ± 3.4 vs 46.17 ± 10.2 | 7.2 (18.4) | ≤ 0.05a | 0.94 |
| Candow and Burke [ | 15 | 42.5 (± 15.5) | 6 weeks | BP | 2–3 (10) | 2 | MF | 109.4 ± 8.5 vs 140.22 ± 25.1 | 30.8 (28.2) | ≤ 0.05a | 1.64 |
| Schoenfeld et al. [ | 10 | 23.5 (± 2.9) | 4 weeks | BP | 3 (8–12) | 1 | LF | 92.9 ± 21.5 vs 99.4 ± 21 | 6.46 (7.0) | ≤ 0.01a | 0.31 |
| Schoenfeld et al. [ | 10 | 23.5 (± 2.9) | 4 weeks | Sq | 3 (8–12) | 1 | LF | 114.8 ± 31.8 vs 127.1 ± 30.6 | 12.27 (10.7) | ≤ 0.01a | 0.39 |
| Thomas and Burns [ | 10 | 34.2 (± 11) | 8 weeks | HS | 3 (8–12) | 1 | LF | 90.2 ± 41.5 vs 112.0 ± 55.4 | 21.83 (24.2) | ≤ 0.05a | 0.45 |
| Thomas and Burns [ | 10 | 34.2 (± 11) | 8 weeks | CP | 3 (8–12) | 1 | LF | 78.6 ± 40.78 vs 84.4 ± 58.3 | 5.8 (7.4) | ≤ 0.05a | 0.12 |
| Arazi and Asadi [ | 10 | 20.20 (± 1.9) | 8 weeks | BP | 1 (6–12) | 1 | LF | 47.5 ± 10.6 vs 52.5 ± 5.2 | 5.0 (10.6) | ≤ 0.05a | 0.60 |
| Arazi and Asadi [ | 10 | 20.20 (± 1.9) | 8 weeks | LP | 1 (6–12) | 1 | LF | 87.5 ± 17.5 vs 95.0 ± 19.3 | 7.5 (8.6) | ≤ 0.05a | 0.41 |
Abbreviations: N number of subjects, SD standard deviation, reps repetitions, per week number of days trained per week, ES effect size, Sq squat, BP bench press, MF medium frequency (2 days per week), HF high frequency (≥ 3 day per week), LPull lateral pulldown, LF low frequency (1 day per week), TriPush tricep pushdown, BC bicep curl, LatR lateral raise, LP leg press, LE leg extension, LC leg curl, CR calf raise, EFlex elbow flexion, CF chest fly, ArmC arm curl, SDip seated dip, TriPull tricep pulldown, HS hack squat
aSignificantly greater than prior to training (p ≤ 0.05)
bSignificant differences from corresponding groups-exercise values (p ≤ 0.05)
cSignificantly greater than prior to training (p ≤ 0.01)
Fig. 5Funnel plot of standard error (SE) by the standard mean difference (SMD) for assessment of publication bias with included resistance training frequency studies (Schoenfeld et al. [50] data excluded). Each open circle denotes a study included in the meta-analysis. The blue dashed vertical line represents the overall effect calculated with the random-effects model
Fig. 6Low vs. medium weekly training frequency. Pre- vs. post-mean ES strength difference on multi-joint and isolation exercises. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 7Low vs. high weekly training frequency. Pre- vs. post-mean ES strength difference on multi-joint and isolation exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 8Medium vs. high weekly training frequency. Pre- vs. post-mean ES strength difference on multi-joint and isolation exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 9Low vs. high weekly training frequency. Pre- vs. post-mean ES strength difference on volume-equated multi-joint and isolation exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 10Low vs. high weekly training frequency. Pre- vs. post-mean ES strength difference on upper body exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 11Low vs. medium weekly training frequency. Pre- vs. post-mean ES strength difference on upper body exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 12Low vs. high weekly training frequency. Pre- vs. post-mean ES strength difference on lower body exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 13Medium vs. high weekly training frequency. Pre- vs. post-mean ES strength difference on lower body exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates
Fig. 14Lower vs. higher weekly training frequency. Pre- vs. post-mean ES strength difference on isolation exercise. The vertical line indicates the overall estimate of combined multi-joint and isolation studies pre- vs. post-mean ES strength difference. Horizontal lines indicate 95% CI, squares estimates, whereas square size is proportional to sample size, and rhombs’ meta-analytically pooled estimates